Makker Gotham's Form 4 filing
Rocket Pharmaceuticals, Inc. (RCKT) · filed Mar 25, 2024
- Accession no.
- 0001140361-24-015103
- Filed
- Mar 25, 2024
- Trade date
- Mar 21, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $7.79M. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0001140361-24-029438 (Jun 10, 2024). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Makker GothamCIK 0001726391 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 21, 2024 | Common Stock | SSaleDisposed | −274,000 | $28.43 | −$7,789,820 | 365,912 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.